Atlas Trials

An Open-label, Randomised Multicenter Phase 3b Study to Determine the Confirmed Rate of Molecular Response ≥ 4 Log (MR4) at Two Years

Clinical trial NCT02174445 · TERMINATED

Trial details

NCT number
NCT02174445
Sponsor
Prof. Dr. Nikolas von Bubnoff
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Myeloid Leukemia
Start date
2014-03-01
Primary completion
2018-12-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.